SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-21-004153
Filing Date
2021-04-14
Accepted
2021-04-14 07:50:42
Documents
70
Period of Report
2021-02-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form6-k.htm 6-K 25928
2 MANAGEMENT DISCUSSION AND ANALYSIS ex991.htm EX-99.1 517405
3 CONDENSED UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS ex992.htm EX-99.2 922284
4 NEWS RELEASE DATED APRIL 14, 2021 ex993.htm EX-99.3 201095
5 FORM 52-109F2 CHIEF EXECUTIVE OFFICER ex994_ceo.htm EX-99.4 17584
6 FORM 52-109F2 - CHIEF FINANCIAL OFFICER ex995_cfo.htm EX-99.5 17587
7 IMAGE intellipharmaceutics_logo.jpg GRAPHIC 7239
  Complete submission text file 0001654954-21-004153.txt   4363755

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ipci-20210228.xml EX-101.INS 687040
9 XBRL TAXONOMY EXTENSION SCHEMA ipci-20210228.xsd EX-101.SCH 49151
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipci-20210228_cal.xml EX-101.CAL 38655
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipci-20210228_def.xml EX-101.DEF 85465
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipci-20210228_lab.xml EX-101.LAB 236167
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipci-20210228_pre.xml EX-101.PRE 172845
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 000-53805 | Film No.: 21824545
SIC: 2834 Pharmaceutical Preparations